Outcome Of Bench Trial Disputed By Patent Owners In Federal Circuit Appeal
WASHINGTON, D.C. — A Delaware federal judge’s ruling, following a bench trial, that four patents covering thrice-weekly injections of 40 mg glatiramer acetate (GA) are invalid was erroneous, the makers of...To view the full article, register now.
Already a subscriber? Click here to view full article